Austin, TX 12/10/2007 11:22:19 PM
Speak with other shareholders about: (OTCBB: UTUC), (OTCBB: ACTC), (OTCBB: TAMO).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.
----------------------------------------------------------
Chat real-time with other investors about this UTUC news release,
by clicking this link: http://www.stockwire.com/UTUC
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=UTUC
Utah Uranium Corp. (OTCBB: UTUC) up 3.2% on 176,000 shares traded.
Utah Uranium Corporation is a Moab, Utah based junior exploration and development company focused on the acquisition of past producing underground uranium mines, highly prospective new uranium projects and other conventional and non-conventional energy projects. On Dec. 6th 2007, the company was pleased to announce the completion of the first 10 holes of the first phase of drilling operations on the Company's Pinto Project, located near Hanksville, UT. Material collected from the drilling has been sent to ALS Chemex Lab in Elko, Nevada for analyses. Results are expected in the next few weeks. In addition, results from down-hole Gamma Ray/SP/SPR logging of the drill holes, performed by Jet West Geophysical Services LLC, are also expected shortly.
----------------------------------------------------------
Chat real-time with other investors about this ACTC news release,
by clicking this link: http://www.stockwire.com/ACTC
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=ACTC
Advanced Cell Technology, Inc. (OTCBB: ACTC) up 2.2% on 513,000 shares traded.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts. On Dec. 6th 2007, the company announced that it is seeking international partners for each of its three lead therapeutic programs, including its Myoblast program for treating heart failure, its Retinal Pigment Epithelium program for treating degenerative retinal disease, and the Hemangioblast program for the treatment of blood and cardiovascular indications. The company is making significant progress in the development of each of these therapeutic programs within the United States.
----------------------------------------------------------
Chat real-time with other investors about this TAMO news release,
by clicking this link: http://www.stockwire.com/TAMO
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=TAMO
Tamm Oil and Gas Corp. (OTCBB: TAMO) up 1.6% on 143,000 shares traded.
Tamm Oil and Gas Corp. will become a sizable stake holder in the prolific Oil Sands Region of Alberta almost overnight. On Dec. 6th 2007, the company was pleased to announce that the they have entered into a Share Exchange Agreement with Shareholders of Deep Well Oil & Gas, Inc. wherein Tamm will acquire 31,800,000 shares of Deep Well, which based on 83 million Deep Well shares outstanding, represents 38% of Deep Well's holdings in Sawn Lake, in exchange for 31,800,000 shares of Tamm Oil and Gas. The share exchange will increase Tamm's working interest substantially in 63 sections of Oil Sands leases in the Sawn Lake Region in Northern Alberta. Through the combination of this share exchange, a pending acquisition and an earlier announced Gross Overriding Royalty Rights ("GORR") acquisition, Tamm will hold directly and indirectly, a majority interest in the project containing an estimated 819.5 million initial barrels of oil in place.
--------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
